Dealing in Securities by an Associate of a Director of the Company ASPEN PHARMACARE HOLDINGS LIMITED Incorporated in the Republic of South Africa Registration number: 1985/002935/06 JSE Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 ("Aspen" or "the Group") DEALING IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR OF THE COMPANY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: Director: Stephen Bradley Saad Associate: K2019068922 (South Africa) Pty Ltd of which Stephen Bradley Saad is a director Date of transaction: 06 May 2025 Nature of transaction: On-market purchase of shares Number of securities: 386,152 Price per security: 11,952.40 cents Value of Transaction: R46,154,431.65 Class of securities: Ordinary shares Nature of interest: Indirect beneficial Clearance obtained: Yes Director: Stephen Bradley Saad Associate: K2019068922 (South Africa) Pty Ltd of which Stephen Bradley Saad is a director Date of transaction: 07 May 2025 Nature of transaction: On-market purchase of shares Number of securities: 467,814 Price per security: 11,891.20 cents Value of Transaction: R55,628,698.00 Class of securities: Ordinary shares Nature of interest: Indirect beneficial Clearance obtained: Yes 08 May 2025 Sponsor: Investec Bank Limited Date: 08-05-2025 12:25:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.